Career Workshop for Life Science: Start-up and Career Options in Europe and in Taiwan

Webinar available for ETBA members!

Time: 1:00  PM (CET, 瑞士時間), June 30th, 2018

Venue: Universitätsspital Basel
Hebelstrasse 20, 4031 Basel (1 OG, Klein Hörsaal ZLF)

13:00 – 13:05 Opening Remark
13:05 – 13:20 My career journey: from an engineer, a physician, to a pharmaceutical executive
13:20 – 13:40 BaseLaunch Accelerator for life science start-ups
13:40 – 14:00 The DayOne acceleration program (Digital Health)
14:00 – 14:20 Pitching your business plan to VCs: Dos and Don’ts
14:20 – 14:40 Career perspective: working in a multinational company v.s. running your own company
14:40 – 15:00 Career opportunities in Taiwan
15:00 – 16:00 Taiwanese Apéro, networking, elevator pitch

This workshop features seasoned domain experts presenting several key aspects when considering your career options in the life science landscape. It includes topics such as career path across different disciplines, funding opportunities for start-ups, accelerator programs in Basel for life science companies as well as for digital healthcare using AI/machine learning/blockchain technologies, and vital advice on pitching your business proposals to Venture Capitals. Furthermore, the expectations that you should be equipped between working in an established company versus running your own one will also be illustrated.

Last but not least, exciting career opportunities in Taiwan will also be shared!



本次的歐洲生技創業主題涵括生技領域求職及創業必備的知識,例如諾華藥廠(Novartis AG)的首席醫學長將暢談從工程師,轉行醫生,及最後進入製藥業擔任高層決策者的個人經驗,兩個瑞士巴塞爾創業加速器的介紹(生物科技加速器以及結合人工智慧,區塊鏈技術的數位醫療),商業計劃書撰寫的重點及跟創投募資時一定要注意的細節。另外,瑞士醫療儀器公司HSE AG的執行長將跟大家現身說法分享他個人自行創業以及大公司擔任高層的主要區別。內容精彩,千萬別錯過!


本次活動將在瑞士巴塞爾舉辦,巴塞爾是歐洲生技重鎮,除此之外也是瑞士的文化中心(Cultural Center),我們預計在會後安排諾華總部的參訪,歡迎大家前來一起切磋認識,希望到時可以與您相見!🙂

Note: The tickets are not refundable once sold. On-line ticket sale will end on 27th June.
請注意: 門票售出後無法退票。線上售票截止日期: 6月27日
ETBA membership is free of charge. Sign up now!
We accept for the ticket purchase. If you are not able to make payments with these options, please contact us for alternatives.